These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 10903969

  • 1. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V, Claperon N, Fournié-Zaluski MC, Roques BP, Peyroux J.
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [Abstract] [Full Text] [Related]

  • 2. Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat.
    Arbin V, Claperon N, Fournié-Zaluski MC, Roques BP, Peyroux J.
    Br J Pharmacol; 2001 Jun; 133(4):495-502. PubMed ID: 11399666
    [Abstract] [Full Text] [Related]

  • 3. Vasopeptidase inhibitor omapatrilat induces profound insulin sensitization and increases myocardial glucose uptake in Zucker fatty rats: Studies comparing a vasopeptidase inhibitor, angiotensin-converting enzyme inhibitor, and angiotensin II type I receptor blocker.
    Wang CH, Leung N, Lapointe N, Szeto L, Uffelman KD, Giacca A, Rouleau JL, Lewis GF.
    Circulation; 2003 Apr 15; 107(14):1923-9. PubMed ID: 12668518
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
    De Gennaro Colonna V, Rigamonti A, Fioretti S, Bonomo S, Manfredi B, Ferrario P, Bianchi M, Berti F, Muller EE, Rossoni G.
    Eur J Pharmacol; 2005 Jun 15; 516(3):253-9. PubMed ID: 15963975
    [Abstract] [Full Text] [Related]

  • 5. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C, Seidl U, Reinecke A, Riester U, Graf K, Schultheiss HP, Hilgenfeldt U, Unger T.
    Int Immunopharmacol; 2003 Mar 15; 3(3):335-44. PubMed ID: 12639811
    [Abstract] [Full Text] [Related]

  • 6. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat.
    Sulpizio AC, Pullen MA, Edwards RM, Brooks DP.
    J Pharmacol Exp Ther; 2004 Jun 15; 309(3):1141-7. PubMed ID: 14769834
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO, Bispo-da-Silva LB, Oliveira EB, Resende AC, Salgado MC.
    Hypertension; 2007 Jul 15; 50(1):110-5. PubMed ID: 17470724
    [Abstract] [Full Text] [Related]

  • 8. Captopril reverses the reduced vasodilator response to bradykinin in hypertensive pregnant rats.
    Resende AC, Pimentel AM, de Moura RS.
    Clin Exp Pharmacol Physiol; 2004 Nov 15; 31(11):756-61. PubMed ID: 15566389
    [Abstract] [Full Text] [Related]

  • 9. Alteration of flow-induced dilatation in mesenteric resistance arteries of L-NAME treated rats and its partial association with induction of cyclo-oxygenase-2.
    Henrion D, Dechaux E, Dowell FJ, Maclour J, Samuel JL, Lévy BI, Michel JB.
    Br J Pharmacol; 1997 May 15; 121(1):83-90. PubMed ID: 9146891
    [Abstract] [Full Text] [Related]

  • 10. Role of ACE and NEP in bradykinin-induced relaxation and contraction response of isolated porcine basilar artery.
    Miyamoto A, Murata S, Nishio A.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May 15; 365(5):365-70. PubMed ID: 12012022
    [Abstract] [Full Text] [Related]

  • 11. In vivo inhibition of nitric oxide synthesis does not depend on renin-angiotensin system activation.
    Zappellini A, Teixeira SA, Muscará MN, Zatz R, Antunes E, De Nucci G.
    Eur J Pharmacol; 1996 Dec 19; 317(2-3):285-91. PubMed ID: 8997612
    [Abstract] [Full Text] [Related]

  • 12. Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats.
    Damas J, Hallet C, Lefebvre PJ.
    Br J Pharmacol; 2001 Nov 19; 134(6):1312-8. PubMed ID: 11704652
    [Abstract] [Full Text] [Related]

  • 13. Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure.
    Zhang X, Recchia FA, Bernstein R, Xu X, Nasjletti A, Hintze TH.
    J Pharmacol Exp Ther; 1999 Feb 19; 288(2):742-51. PubMed ID: 9918584
    [Abstract] [Full Text] [Related]

  • 14. Neutral endopeptidase and angiotensin-converting enzyme inhibitors increase nitric oxide production in isolated canine coronary microvessels by a kinin-dependent mechanism.
    Zhang X, Nasjletti A, Xu X, Hintze TH.
    J Cardiovasc Pharmacol; 1998 Apr 19; 31(4):623-9. PubMed ID: 9554814
    [Abstract] [Full Text] [Related]

  • 15. Interaction between neutral endopeptidase and angiotensin converting enzyme inhibition in rats with myocardial infarction: effects on cardiac hypertrophy and angiotensin and bradykinin peptide levels.
    Duncan AM, James GM, Anastasopoulos F, Kladis A, Briscoe TA, Campbell DJ.
    J Pharmacol Exp Ther; 1999 Apr 19; 289(1):295-303. PubMed ID: 10087017
    [Abstract] [Full Text] [Related]

  • 16. Effect of DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid on the blood pressure response to vasoactive substances.
    Salgado HC, Carretero OA, Scicli AG, Murray RD.
    J Pharmacol Exp Ther; 1986 Apr 19; 237(1):204-8. PubMed ID: 2420968
    [Abstract] [Full Text] [Related]

  • 17. Role of bradykinin receptors in the renal effects of inhibition of angiotensin converting enzyme and endopeptidases 24.11 and 24.15 in conscious rabbits.
    Tomoda F, Lew RA, Smith AI, Madden AC, Evans RG.
    Br J Pharmacol; 1996 Sep 19; 119(2):365-73. PubMed ID: 8886422
    [Abstract] [Full Text] [Related]

  • 18. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
    Persson K, Andersson RG.
    J Cardiovasc Pharmacol; 1998 Feb 19; 31(2):306-13. PubMed ID: 9475274
    [Abstract] [Full Text] [Related]

  • 19. Nitric oxide modulates captopril-mediated angiotensin-converting enzyme inhibition in porcine iliac arteries.
    Persson K, Andersson RG.
    Eur J Pharmacol; 1999 Nov 26; 385(1):21-7. PubMed ID: 10594341
    [Abstract] [Full Text] [Related]

  • 20. Effects of angiotensin-converting enzyme and neutral endopeptidase inhibitors: influence of bradykinin.
    Pham I, Gonzalez W, Doucet J, Fournie-Zaluski MC, Roques BP, Michel JB.
    Eur J Pharmacol; 1996 Feb 05; 296(3):267-76. PubMed ID: 8904078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.